Limitations of Small Animal PET Imaging with [18F]FDDNP and FDG for Quantitative Studies in a Transgenic Mouse Model of Alzheimer's Disease

被引：73

作者：

Kuntner, Claudia ^{[1
]}

Kesner, Adam L. ^{[5
]}

Bauer, Martin ^{[2
]}

Kremslehner, Robert ^{[1
,6
]}

Wanek, Thomas ^{[1
]}

Mandler, Markus ^{[4
]}

Karch, Rudolf ^{[7
]}

Stanek, Johann ^{[1
]}

Wolf, Tanja ^{[3
]}

Mueller, Markus ^{[2
]}

Langer, Oliver ^{[1
,2
]}

机构：

[1] Austrian Res Ctr GmbH, Dept Radiopharmaceut & MicroPET Imaging, A-2444 Seibersdorf, Austria

[2] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria

[3] Austrian Res Ctrs GmbH, Dept Toxicol, A-2444 Seibersdorf, Austria

[4] AFFiRiS GmbH, Vienna, Austria

[5] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA

[6] Univ Technol, Inst Solid State Phys, Vienna, Austria

[7] Med Univ Vienna, Dept Med Comp Sci, Vienna, Austria

来源：

MOLECULAR IMAGING AND BIOLOGY | 2009年 / 11卷 / 04期

关键词：

Alzheimer's disease (AD); PET; F-18]FDDNP; FDG; Transgenic mouse; Amyloid-beta (A beta); PITTSBURGH COMPOUND-B; POSITRON-EMISSION-TOMOGRAPHY; AMYLOID-BETA; BRAIN; BINDING; PATHOLOGY; TARGET; MICE;

D O I：

10.1007/s11307-009-0198-z

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

We evaluated the usefulness of small animal brain positron emission tomography (PET) imaging with the amyloid-beta (A beta) probe 2-(1-{6-[(2-[F-18]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malonitrile ([F-18]FDDNP) and with 2-deoxy-2-[F-18]fluoro-d-glucose (FDG) for detection and quantification of pathological changes occurring in a transgenic mouse model of Alzheimer's disease (Tg2576 mice). [F-18]FDDNP (n = 6) and FDG-PET scans (n = 3) were recorded in Tg2576 mice (age 13-15 months) and age-matched wild-type litter mates. Brain volumes of interest were defined by co-registration of PET images with a 3D MOBY digital mouse phantom. Regional [F-18]FDDNP retention in mouse brain was quantified in terms of the relative distribution volume (DVR) using Logan's graphical analysis with cerebellum as a reference region. Except for a lower maximum brain uptake of radioactivity in transgenic animals, the regional brain kinetics as well as DVR values of [F-18]FDDNP appeared to be similar in both groups of animals. Also for FDG, regional radioactivity retention was almost identical in the brains of transgenic and control animals. We could not detect regionally increased [F-18]FDDNP binding and regionally decreased FDG binding in the brains of Tg2576 transgenic versus wild-type mice. However, small group differences in signal might have been masked by inter-animal variability. In addition, technical limitations of the applied method (partial volume effect, spatial resolution) for measurements in such small organs as mouse brain have to be taken into consideration.

引用

页码：236 / 240

页数：5

共 24 条

[1]

Agdeppa Eric D, 2003, Mol Imaging Biol, V5, P404, DOI 10.1016/j.mibio.2003.09.010

[2] γ-secretase as a therapeutic target for the treatment of Alzheimer's disease [J].

Churcher, I ;

Beher, D .

CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (26) :3363-3382

[3]

Kepe V, 2005, J LABELLED COMPD RAD, V48, pS43

[4]

Kesner AL, 2006, J NUCL MED, V47, P1181

[5] Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-β in Alzheimer's disease brain but not in transgenic mouse brain [J].

Klunk, WE ;

Lopresti, BJ ;

Ikonomovic, MD ;

Lefterov, IM ;

Koldamova, RP ;

Abrahamson, EE ;

Debnath, ML ;

Holt, DP ;

Huang, GF ;

Shao, L ;

DeKosky, ST ;

Price, JC ;

Mathis, CA .

JOURNAL OF NEUROSCIENCE, 2005, 25 (46) :10598-10606

[6]

Klunk WE, 2003, J NEUROSCI, V23, P2086

[7] Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B [J].

Klunk, WE ;

Engler, H ;

Nordberg, A ;

Wang, YM ;

Blomqvist, G ;

Holt, DP ;

Bergström, M ;

Savitcheva, I ;

Huang, GF ;

Estrada, S ;

Ausén, B ;

Debnath, ML ;

Barletta, J ;

Price, JC ;

Sandell, J ;

Lopresti, BJ ;

Wall, A ;

Koivisto, P ;

Antoni, G ;

Mathis, CA ;

Långström, B .

ANNALS OF NEUROLOGY, 2004, 55 (03) :306-319

[8]

KREMSLEHNER R, 2007, NUKLEARMEDIZIN, V46, pA159

[9] High-yield, automated radiosynthesis of 2-(1-{6-[(2-[18F]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile ([18F]FDDNP) ready for animal or human administration [J].

Liu, Jie ;

Kepe, Vladimir ;

Zabjek, Alenka ;

Petric, Andrej ;

Padgett, Henry C. ;

Satyamurthy, Nagichettiar ;

Barrio, Jorge R. .

MOLECULAR IMAGING AND BIOLOGY, 2007, 9 (01) :6-16

[10] Imaging Alzheimer's disease pathology: one target, many ligands [J].

Lockhart, Andrew .

DRUG DISCOVERY TODAY, 2006, 11 (23-24) :1093-1099

← 1 2 3 →